These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25006347)

  • 21. Patenting Nucleic Acid Sequences: More Ambiguity from the High Court?
    Lawson C
    J Law Med; 2018 Apr; 25(3):741-764. PubMed ID: 29978665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continental drift? Do European clinical genetic testing laboratories have a patent problem?
    Liddicoat J; Liddell K; McCarthy AH; Hogarth S; Aboy M; Nicol D; Patton S; Hopkins MM
    Eur J Hum Genet; 2019 Jul; 27(7):997-1007. PubMed ID: 30846855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mayo, Myriad, America Invents Act and BPCIA: how has the United States biopharmaceutical market been affected?
    Finston SK; Davey NS; Davé E; Ravichandran V; Davey SR; Davé RS
    Pharm Pat Anal; 2016 May; 5(3):159-67. PubMed ID: 27087460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
    Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patenting human genes: Chinese academic articles' portrayal of gene patents.
    Du L
    BMC Med Ethics; 2018 Apr; 19(1):29. PubMed ID: 29699570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioengineered bugs, drugs and contentious issues in patenting.
    Chakrabarty AM
    Bioeng Bugs; 2010; 1(1):2-8. PubMed ID: 21327122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inventions and Patents: A Practical Tutorial.
    Mehta H; Tidwell L; Liotta LA
    Methods Mol Biol; 2017; 1606():379-397. PubMed ID: 28502014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The patenting of novel biotech products.
    Webber PM
    IDrugs; 2007 Jul; 10(7):459-62. PubMed ID: 17642015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supreme Court to Myriad Genetics: Synthetic DNA is Patentable but Isolated Genes Are Not.
    Weinmeyer R; Klusty T
    AMA J Ethics; 2015 Sep; 17(9):849-53. PubMed ID: 26390207
    [No Abstract]   [Full Text] [Related]  

  • 30. Is Patent "Evergreening" Restricting Access to Medicine/Device Combination Products?
    Beall RF; Nickerson JW; Kaplan WA; Attaran A
    PLoS One; 2016; 11(2):e0148939. PubMed ID: 26910128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Must an inventor "possess" an invention to patent it?
    Woessner WD; Chadwick RA
    Cold Spring Harb Perspect Med; 2014 Sep; 4(11):a020867. PubMed ID: 25237144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene patents, patenting life and the impact of court rulings on US stem cell patents and research.
    Matthews KR; Cuchiara ML
    Regen Med; 2014 Mar; 9(2):191-200. PubMed ID: 24750060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are natural products and medical diagnostic tests still eligible for patents in the USA?
    Cockbain J; Sterckx S
    Pharm Pat Anal; 2012 Sep; 1(4):365-70. PubMed ID: 24236874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Life forms protectable as subjects of U.S. patents -- microbes to animals (perhaps).
    Hodgins DS
    Biomater Artif Cells Artif Organs; 1989; 17(2):205-24. PubMed ID: 2775879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patents, Governance and Control: Ethics and the Patentability of Novel Beings and Advanced Biotechnologies in Europe.
    McMahon A
    Camb Q Healthc Ethics; 2021 Jul; 30(3):529-542. PubMed ID: 34109920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LabCorp v. Metabolite Laboratories: The Supreme Court listens, but declines to speak.
    Klein RD; Mahoney MJ
    J Law Med Ethics; 2008; 36(1):141-9, 4. PubMed ID: 18315767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patenting genetic diagnostic methods: NGS, GWAS, SNPs and patents.
    Lawson C
    J Law Med; 2015 Jun; 22(4):846-63. PubMed ID: 26349382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of patent eligibility on biotech patents: A flow chart for determining patent eligibility and an immune therapy case study.
    Chang BC; Wang SJ
    Hum Vaccin Immunother; 2015; 11(3):789-94. PubMed ID: 25714661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patentability of genetically engineered microorganisms.
    Cooper A
    JAMA; 1983 Mar; 249(12):1553-4. PubMed ID: 6338261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.